<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Solifenacin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Solifenacin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Solifenacin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Solifenacin</b>, sold as the brand name <b>Vesicare</b> among others, is a medicine used to treat overactive bladder and neurogenic detrusor overactivity (NDO).<span class="mw-ref" id="cite_ref-AHFS2019_1-0"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FDA_PR_2-0"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It may help with incontinence, urinary frequency, and urinary urgency.<span class="mw-ref" id="cite_ref-BNF76_3-0"><a href="#cite_note-BNF76-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Benefits appear similar to other medications in the class.<span class="mw-ref" id="cite_ref-TI93_4-0"><a href="#cite_note-TI93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_1-1"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Solifenacin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Solifenacin_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Solifenacin_structure.svg.png" data-file-width="512" data-file-height="341" data-file-type="drawing" height="147" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Vesicare, Vesicare LS</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>YM905</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/solifenacin-succinate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/solifenacin-succinate.html'" tppabs="https://www.drugs.com/monograph/solifenacin-succinate.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a605019.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a605019.html'" tppabs="https://medlineplus.gov/druginfo/meds/a605019.html" class="external text external">a605019</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Solifenacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Solifenacin'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Solifenacin" class="external text external">Solifenacin</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Solifenacin&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Solifenacin&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Solifenacin&SearchType=BasicSearch" class="external text external">Solifenacin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G04BD08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G04BD08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G04BD08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G04BD08" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>90%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>98%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>CYP3A4</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>Glucuronide, <i>N</i>-oxide, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>45 to 68 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney (69.2%) and fecal (22.5%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(3<i>R</i>)-1-Azabicyclo[2 2 2]oct-3-yl (1<i>S</i>)-1-phenyl-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=242478-37-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=242478-37-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=242478-37-1" class="external text external">242478-37-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/154059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/154059'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/154059" class="external text external">154059</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7483'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7483" class="external text external">7483</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01591  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01591'" tppabs="https://www.drugbank.ca/drugs/DB01591" class="external text external">DB01591</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.135771.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.135771.html'" tppabs="http://www.chemspider.com/Chemical-Structure.135771.html" class="external text external">135771</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A8910SQJ1U  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A8910SQJ1U'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A8910SQJ1U" class="external text external">A8910SQJ1U</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/DG00481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/DG00481'" tppabs="https://www.kegg.jp/entry/DG00481" class="external text external">DG00481</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1734  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1734'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1734" class="external text external">ChEMBL1734</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3048289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3048289'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3048289" class="external text external">DTXSID3048289</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>23</sub><span>H</span><sub>26</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">362.473</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=C1CN2CCC1%5BC%40H%5D%28C2%29OC%28%3DO%29N3CCC4%3DCC%3DCC%3DC4%5BC%40%40H%5D3C5%3DCC%3DCC%3DC5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=C1CN2CCC1%5BC%40H%5D%28C2%29OC%28%3DO%29N3CCC4%3DCC%3DCC%3DC4%5BC%40%40H%5D3C5%3DCC%3DCC%3DC5'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=C1CN2CCC1%5BC%40H%5D%28C2%29OC%28%3DO%29N3CCC4%3DCC%3DCC%3DC4%5BC%40%40H%5D3C5%3DCC%3DCC%3DC5" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:FBOUYBDGKBSUES-VXKWHMMOSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461941706&page2=Solifenacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461941706&page2=Solifenacin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461941706&page2=Solifenacin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include dry mouth, constipation, and urinary tract infection.<span class="mw-ref" id="cite_ref-AHFS2019_1-2"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FDA_PR_2-1"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Severe side effects may include urinary retention, QT prolongation, hallucinations, glaucoma, and anaphylaxis.<span class="mw-ref" id="cite_ref-AHFS2019_1-3"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-BNF76_3-1"><a href="#cite_note-BNF76-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-FDA_PR_2-2"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is unclear if use is safe during pregnancy.<span class="mw-ref" id="cite_ref-AHFS2019_1-4"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is of the antimuscarinic class and works by decreasing bladder contractions.<span class="mw-ref" id="cite_ref-AHFS2019_1-5"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Solifenacin was approved for medical use in the United States in 2004.<span class="mw-ref" id="cite_ref-AHFS2019_1-6"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FDA_PR_2-3"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-FDA_approval_5-0"><a href="#cite_note-FDA_approval-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A month's supply in the United Kingdom costs the NHS about £27.62 as of 2019.<span class="mw-ref" id="cite_ref-BNF76_3-2"><a href="#cite_note-BNF76-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In the United States the wholesale cost of this amount is about US$370.<span class="mw-ref" id="cite_ref-NADAC2019_6-0"><a href="#cite_note-NADAC2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In 2017, it was the 283rd most commonly prescribed medication in the United States, with more than one million prescriptions.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    
<p>It is used to treat overactive bladder.<span class="mw-ref" id="cite_ref-AHFS2019_1-7"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may help with incontinence, urinary frequency, and urinary urgency.<span class="mw-ref" id="cite_ref-BNF76_3-3"><a href="#cite_note-BNF76-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Benefits appear similar to other antimuscarinics such as <a href="Oxybutynin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxybutynin" title="Oxybutynin">oxybutynin</a>, <a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">tolterodine</a>, and <a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">darifenacin</a>.<span class="mw-ref" id="cite_ref-TI93_4-1"><a href="#cite_note-TI93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>It is also used to treat neurogenic detrusor overactivity (NDO), a form of bladder dysfunction related to neurological impairment, in children ages two years and older.<span class="mw-ref" id="cite_ref-FDA_PR_2-4"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> NDO is a dysfunction of the bladder that results from disease or injury in the nervous system.<span class="mw-ref" id="cite_ref-FDA_PR_2-5"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> NDO may be related to congenital conditions (often-inherited conditions beginning at or before birth), such as spina bifida (myelomeningocele), or other conditions such as spinal cord injury.<span class="mw-ref" id="cite_ref-FDA_PR_2-6"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> With NDO, there is overactivity of the bladder wall muscle, which normally relaxes to allow storage of urine.<span class="mw-ref" id="cite_ref-FDA_PR_2-7"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The bladder wall muscle overactivity results in sporadic bladder muscle contraction, which increases pressure in the bladder and decreases the volume of urine the bladder can hold.<span class="mw-ref" id="cite_ref-FDA_PR_2-8"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> If NDO is not treated, increased pressure in the bladder can put the upper urinary tract at risk of harm, including possible permanent damage to the kidneys.<span class="mw-ref" id="cite_ref-FDA_PR_2-9"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In addition, spontaneous bladder muscle contractions can lead to unexpected and frequent leakage of urine with symptoms of urinary urgency (immediate urge to urinate), frequency (urinating more often than normal) and incontinence (loss of bladder control).<span class="mw-ref" id="cite_ref-FDA_PR_2-10"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Solifenacin is contraindicated for people with urinary retention, gastric retention, uncontrolled or poorly controlled closed-angle glaucoma, severe liver disease (Child-Pugh class C),<span class="mw-ref" id="cite_ref-Lexi-Comp_9-0"><a href="#cite_note-Lexi-Comp-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> and hemodialysis.<span class="mw-ref" id="cite_ref-Austria-Codex_10-0"><a href="#cite_note-Austria-Codex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Long QT syndrome is not a contraindication although solifenacin, like <a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">tolterodine</a> and <a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">darifenacin</a>, binds to hERG channels of the heart and may prolong the QT interval. This mechanism appears to be seldom clinically relevant.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Solifenacin is not to be used in people with gastric retention (reduced emptying of the stomach), uncontrolled narrow angle glaucoma (fluid buildup in the eye which raises eye pressure) or hypersensitivity (allergic reaction) to solifenacin or any of its components.<span class="mw-ref" id="cite_ref-FDA_PR_2-11"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Solifenacin is also not recommended for use in people with severe liver failure, clinically significant bladder outlet obstruction in the absence of clean intermittent catheterization, decreased gastrointestinal motility (slowed intestinal contractions), or at high risk of QT prolongation (an electrical disturbance where the heart muscle takes longer than normal to recharge between beats), including people with a known history of QT prolongation and people taking medications known to prolong the QT interval.<span class="mw-ref" id="cite_ref-FDA_PR_2-12"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    

<p>The most common side effects of solifenacin are dry mouth, constipation and urinary tract infection.<span class="mw-ref" id="cite_ref-FDA_PR_2-13"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> As all anticholinergics, solifenacin may rarely cause hyperthermia due to decreased perspiration.<span class="mw-ref" id="cite_ref-Lexi-Comp_9-1"><a href="#cite_note-Lexi-Comp-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Somnolence (sleepiness or drowsiness) has been reported.<span class="mw-ref" id="cite_ref-FDA_PR_2-14"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Severe allergic reactions, such as angioedema (swelling beneath the skin) and anaphylaxis, have been reported in people treated with solifenacin succinate and may be life-threatening.<span class="mw-ref" id="cite_ref-FDA_PR_2-15"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Solifenacin is metabolized in the liver by the cytochrome P450 enzyme CYP3A4. When administered concomitantly with drugs that inhibit CYP3A4, such as <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a>, the metabolism of solifenacin is impaired, leading to an increase in its concentration in the body and a reduction in its excretion.<span class="mw-ref" id="cite_ref-Lexi-Comp_9-2"><a href="#cite_note-Lexi-Comp-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>As stated above, solifenacin may also prolong the QT interval. Therefore, administering it concomitantly with drugs which also have this effect, such as <a href="Moxifloxacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Moxifloxacin" title="Moxifloxacin">moxifloxacin</a> or <a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">pimozide</a>, can theoretically increase the risk of arrhythmia.<span class="mw-ref" id="cite_ref-AHFS2019_1-8"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>Solifenacin is a competitive cholinergic receptor antagonist, selective for the M<sub>3</sub> receptor subtype. The binding of <a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">acetylcholine</a> to these receptors, particularly M<sub>3</sub>, plays a critical role in the contraction of smooth muscle.
By preventing the binding of acetylcholine to these receptors, solifenacin reduces smooth muscle tone in the bladder, allowing the bladder to retain larger volumes of urine and reducing the number of micturition, urgency and incontinence episodes. Because of a long elimination half life, a once-a-day dose can offer 24-hour control of the urinary bladder smooth muscle tone.<span class="mw-ref" id="cite_ref-Austria-Codex_10-1"><a href="#cite_note-Austria-Codex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Peak plasma concentrations are reached three to eight hours after absorption from the gut. In the bloodstream, 98% of the substance are bound to plasma proteins, mainly acidic ones. Metabolism is mediated by the liver enzyme CYP3A4 and possibly others. There is one known active metabolite, 4<i>R</i>-hydroxysolifenacin, and three inactive ones, the <i>N</i>-glucuronide, the <i>N</i>-oxide and the 4<i>R</i>-hydroxy-<i>N</i>-oxide. The elimination half-life is 45 to 68 hours. 69% of the substance, both in its original form and as metabolites, are excreted renally and 23% via the feces.<span class="mw-ref" id="cite_ref-Austria-Codex_10-2"><a href="#cite_note-Austria-Codex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Atropine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Atropine.svg.png" data-file-width="512" data-file-height="317" data-file-type="drawing" height="136" width="220"><div class="thumbcaption" style="text-align: left"><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a> for comparison</div></div></div>
<p>Like other anticholinergics, solifenacin is an ester of a carboxylic acid containing (at least) an aromatic ring with an alcohol containing a nitrogen atom. While in the prototype anticholinergic <a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">atropine</a> the bicyclic ring is <a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">tropane</a>, solifenacin replaces it with <a href="Quinuclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinuclidine" title="Quinuclidine">quinuclidine</a>.</p>

<p>The free base is a yellow oil, while the salt solifenacin <a href="Succinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Succinate" title="Succinate" class="mw-redirect">succinate</a> forms yellowish crystals.<span class="mw-ref" id="cite_ref-MerckIndex_12-0"><a href="#cite_note-MerckIndex-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The compound was studied using animal models by the Yamanouchi Pharmaceutical Co., Ltd. of Tokyo, Japan. It was known as YM905 when under study in the early 2000s.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Solifenacin was approved for medical used in the United States in 2004 with an indication to treat overactive bladder in adults 18 years and older.<span class="mw-ref" id="cite_ref-FDA_PR_2-16"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-FDA_approval_5-1"><a href="#cite_note-FDA_approval-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>In May 2020, solifenacin was approved for medical use in the United States with an indication to treat neurogenic detrusor overactivity (NDO), a form of bladder dysfunction related to neurological impairment, in children ages two years and older.<span class="mw-ref" id="cite_ref-FDA_PR_2-17"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>The efficacy of solifenacin to treat neurogenic detrusor overactivity (NDO) was established in two clinical trials with a total of 95 pediatric NDO participants, ages two to 17 years old.<span class="mw-ref" id="cite_ref-FDA_PR_2-18"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The studies were designed to measure (as a primary efficacy endpoint) the maximum amount of urine the bladder could hold after 24 weeks of treatment.<span class="mw-ref" id="cite_ref-FDA_PR_2-19"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In the first study, 17 participants ages two to less than five years old were able to hold an average of 39 mL more urine than when the study began.<span class="mw-ref" id="cite_ref-FDA_PR_2-20"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In the second study, 49 participants ages five to 17 years were able to hold an average of 57 mL more urine than when the study began.<span class="mw-ref" id="cite_ref-FDA_PR_2-21"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Reductions in spontaneous bladder contractions, bladder pressure and number of incontinence episodes were also observed in both studies.<span class="mw-ref" id="cite_ref-FDA_PR_2-22"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The approval of Vesicare LS was granted to Astellas Pharma US, Inc.<span class="mw-ref" id="cite_ref-FDA_PR_2-23"><a href="#cite_note-FDA_PR-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<p>The INN is solifenacin.<span class="mw-ref" id="cite_ref-INN_14-0"><a href="#cite_note-INN-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It is manufactured and marketed by Astellas, GlaxoSmithKline<span class="mw-ref" id="cite_ref-AHFS2019_1-9"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> and Teva Pharmaceutical Industries.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<p>A 2006 cost-effectiveness study found that 5<span>&nbsp;</span>mg solifenacin had the lowest cost and highest effectiveness among anticholinergic drugs used to treat overactive bladder in the United States, with an average medical cost per successfully treated patient of $6863 per year.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> By 2019, with the introduction of generics, the retail cost of a month's supply was down to $20 in the US.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2019-1"> <span id="mw-reference-text-cite_note-AHFS2019-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/solifenacin-succinate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/solifenacin-succinate.html'" tppabs="https://www.drugs.com/monograph/solifenacin-succinate.html" class="external text external">"Solifenacin Succinate Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists.</cite></span></li><li id="cite_note-FDA_PR-2"> <span id="mw-reference-text-cite_note-FDA_PR-2" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-form-bladder-dysfunction-pediatric-patients-young-2-years-age  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-form-bladder-dysfunction-pediatric-patients-young-2-years-age'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-form-bladder-dysfunction-pediatric-patients-young-2-years-age" class="external text external">"FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age"</a>. <i>U.S. Food and Drug Administration (FDA)</i> (Press release). 26 May 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">26 May</span> 2020</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-BNF76-3"> <span id="mw-reference-text-cite_note-BNF76-3" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. p.<span>&nbsp;</span>761. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-TI93-4"> <span id="mw-reference-text-cite_note-TI93-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ti.ubc.ca/2015/04/22/are-claims-for-newer-drugs-for-overactive-bladder-warranted/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ti.ubc.ca/2015/04/22/are-claims-for-newer-drugs-for-overactive-bladder-warranted/'" tppabs="https://www.ti.ubc.ca/2015/04/22/are-claims-for-newer-drugs-for-overactive-bladder-warranted/" class="external text external">"<span>[</span>93<span>]</span> Are claims for newer drugs for overactive bladder warranted?"</a>. <i>Therapeutics Initiative</i>. 22 April 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">17 March</span> 2019</span>.</cite></span></li><li id="cite_note-FDA_approval-5"> <span id="mw-reference-text-cite_note-FDA_approval-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-518_VesiCare.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-518_VesiCare.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-518_VesiCare.cfm" class="external text external">"Drug Approval Package: VesiCare (Solifenacin Succinate) NDA #021518"</a>. <i>U.S. Food and Drug Administration (FDA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 May</span> 2020</span>.</cite></span></li><li id="cite_note-NADAC2019-6"> <span id="mw-reference-text-cite_note-NADAC2019-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6" class="external text external">"NADAC as of 2019-02-27"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/SolifenacinSuccinate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/SolifenacinSuccinate'" tppabs="https://clincalc.com/DrugStats/Drugs/SolifenacinSuccinate" class="external text external">"Solifenacin Succinate - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Lexi-Comp-9"> <span id="mw-reference-text-cite_note-Lexi-Comp-9" class="mw-reference-text"><cite id="CITEREFLexi-Comp2009" class="citation web cs1">Lexi-Comp (December 2009). <a href="javascript:if(confirm('http://www.merck.com/mmpe/lexicomp/solifenacin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.merck.com/mmpe/lexicomp/solifenacin.html'" tppabs="http://www.merck.com/mmpe/lexicomp/solifenacin.html" class="external text external">"Solifenacin"</a>. <i>The Merck Manual Professional</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2011</span>.</cite></span></li><li id="cite_note-Austria-Codex-10"> <span id="mw-reference-text-cite_note-Austria-Codex-10" class="mw-reference-text"><cite id="CITEREFJasek,_W2007" class="citation book cs1">Jasek, W, ed. (2007). <i>Austria-Codex</i> (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. pp.<span>&nbsp;</span>8659–62. ISBN<span>&nbsp;</span><bdi>978-3-85200-181-4</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/14900  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/14900'" tppabs="https://www.medicines.org.uk/emc/medicine/14900" class="external text external">"Vesicare 5mg <span>&amp;</span> 10mg film-coated tablets"</a>. eMC<span class="reference-accessdate">. Retrieved <span class="nowrap">13 December</span> 2015</span>.</cite></span></li><li id="cite_note-MerckIndex-12"> <span id="mw-reference-text-cite_note-MerckIndex-12" class="mw-reference-text"><cite class="citation book cs1"><i>The Merck Index. An Encyclopaedia of Chemicals, Drugs and Biologicals</i> (14 ed.). 2006. p.<span>&nbsp;</span>1494. ISBN<span>&nbsp;</span><bdi>978-0-911910-00-1</bdi>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFKobayashi,_S.2001" class="citation journal cs1">Kobayashi, S.;  et al. (July 2001). <a href="javascript:if(confirm('https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf'" tppabs="https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf" class="external text external">"Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction In Vivo"</a>. <i>Jpn. J. Pharmacol</i>. <b>86</b> (3): 281–288. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11488427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11488427'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11488427" class="external text external">11488427</a>.</cite></span></li><li id="cite_note-INN-14"> <span id="mw-reference-text-cite_note-INN-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/medicines/publications/druginformation/innlists/RL47.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/druginformation/innlists/RL47.pdf'" tppabs="http://www.who.int/medicines/publications/druginformation/innlists/RL47.pdf" class="external text external">"International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 47"</a> <span class="cs1-format">(PDF)</span>. World Health Organization. p.<span>&nbsp;</span>106<span class="reference-accessdate">. Retrieved <span class="nowrap">5 February</span> 2017</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://news.bloomberglaw.com/pharma-and-life-sciences/teva-introduces-generic-of-vesicare-to-treat-overactive-bladder  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://news.bloomberglaw.com/pharma-and-life-sciences/teva-introduces-generic-of-vesicare-to-treat-overactive-bladder'" tppabs="https://news.bloomberglaw.com/pharma-and-life-sciences/teva-introduces-generic-of-vesicare-to-treat-overactive-bladder" class="external text external">"Teva Introduces Generic of Vesicare to Treat Overactive Bladder"</a>. <i>Bloomberg Law</i>. 22 April 2019.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFKoMaloneArmstrong2006" class="citation journal cs1">Ko Y, Malone DC, Armstrong EP (Dec 2006). <a href="javascript:if(confirm('https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf'" tppabs="https://www.jstage.jst.go.jp/article/jjp/86/3/86_3_281/_pdf" class="external text external">"Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder"</a>. <i>Pharmacotherapy</i>. <b>26</b> (12): 1694–702. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.26.12.1694  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.26.12.1694'" tppabs="https://doi.org/10.1592%2Fphco.26.12.1694" class="external text external">10.1592/phco.26.12.1694</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17125433  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17125433'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17125433" class="external text external">17125433</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/solifenacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/solifenacin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/solifenacin" class="external text external">"Solifenacin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/solifenacin%20succinate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/solifenacin%20succinate'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/solifenacin%20succinate" class="external text external">"Solifenacin succinate"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Urologicals,_including_antispasmodics_(G04B)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Urologicals,_including_antispasmodics_(G04B)" style="font-size:114%;margin:0 4em">Urologicals, including antispasmodics (G04B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Acidifiers</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ammonium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Ammonium_chloride" title="Ammonium chloride">Ammonium chloride</a></li>
<li><a href="Calcium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium_chloride" title="Calcium chloride">Calcium chloride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Urinary antispasmodics<br>(primarily antimuscarinics)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">Darifenacin</a></li>
<li>Desfesoterodine</li>
<li>Emepronium</li>
<li>Fesoterodine</li>
<li><a href="Flavoxate.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavoxate" title="Flavoxate">Flavoxate</a></li>
<li>Imidafenacin</li>
<li>Meladrazine</li>
<li>Mirabegron</li>
<li><a href="Oxybutynin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxybutynin" title="Oxybutynin">Oxybutynin</a></li>
<li>Propiverine</li>
<li><a href="Solifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Solifenacin" title="Solifenacin">Solifenacin</a></li>
<li>Terodiline</li>
<li><a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li><a href="Trospium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Trospium_chloride" title="Trospium chloride">Trospium chloride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other urologicals</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="Urea.htm" tppabs="https://ptable.com/wiki/compounds/A/Urea" title="Urea">Urea</a> analogues:</i> <a href="Acetohydroxamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetohydroxamic_acid" title="Acetohydroxamic acid">Acetohydroxamic acid</a></li>
<li><a href="Salicylhydroxamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylhydroxamic_acid" title="Salicylhydroxamic acid">Salicylhydroxamic acid</a><br></li></ul>

<ul><li><i>Other:</i> Collagen</li>
<li><a href="Dimethyl_sulfoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyl_sulfoxide" title="Dimethyl sulfoxide">Dimethyl sulfoxide</a></li>
<li><a href="Magnesium_hydroxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium_hydroxide" title="Magnesium hydroxide">Magnesium hydroxide</a></li>
<li><a href="Pentosan_polysulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentosan_polysulfate" title="Pentosan polysulfate">Pentosan polysulfate</a></li>
<li><a href="Phenazopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenazopyridine" title="Phenazopyridine">Phenazopyridine</a></li>
<li><a href="Phenyl_salicylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenyl_salicylate" title="Phenyl salicylate">Phenyl salicylate</a></li>
<li><a href="Succinimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Succinimide" title="Succinimide">Succinimide</a></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Muscarinic_acetylcholine_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Muscarinic_acetylcholine_receptor_modulators" style="font-size:114%;margin:0 4em">Muscarinic acetylcholine receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>mAChRs</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>77-LH-28-1</li>
<li><span class="new">AC-42</span></li>
<li><span class="new">AC-260,584</span></li>
<li>Aceclidine</li>
<li><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Acetylcholine</a></li>
<li><span class="new">AF30</span></li>
<li><span class="new">AF150(S)</span></li>
<li><span class="new">AF267B</span></li>
<li>Alvameline</li>
<li><span class="new">AQRA-741</span></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a></li>
<li><a href="Bethanechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bethanechol" title="Bethanechol">Bethanechol</a></li>
<li>Bevonium</li>
<li>Butyrylcholine</li>
<li><a href="Carbachol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbachol" title="Carbachol">Carbachol</a></li>
<li><span class="new">CDD-0034</span></li>
<li><span class="new">CDD-0078</span></li>
<li><span class="new">CDD-0097</span></li>
<li><span class="new">CDD-0098</span></li>
<li><span class="new">CDD-0102</span></li>
<li><a href="Cevimeline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cevimeline" title="Cevimeline">Cevimeline</a></li>
<li><a href="Choline.htm" tppabs="https://ptable.com/wiki/compounds/A/Choline" title="Choline">Choline</a></li>
<li><a href="Dioxolane.htm" tppabs="https://ptable.com/wiki/compounds/A/Cis-Dioxolane" title="Cis-Dioxolane" class="mw-redirect">cis-Dioxolane</a></li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li>Desmethylclozapine (norclozapine)</li>
<li><span class="new">Ethoxysebacylcholine</span></li>
<li><span class="new">Itameline</span></li>
<li><span class="new">LY-593,039</span></li>
<li><span class="new">L-689,660</span></li>
<li><span class="new">LY-2,033,298</span></li>
<li><span class="new">McNA343</span></li>
<li>Methacholine</li>
<li>Milameline</li>
<li>Muscarine</li>
<li><span class="new">NGX-267</span></li>
<li><span class="new">Ocvimeline</span></li>
<li><a href="Oxotremorine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxotremorine" title="Oxotremorine">Oxotremorine</a></li>
<li><span class="new">PD-151,832</span></li>
<li><a href="Pilocarpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pilocarpine" title="Pilocarpine">Pilocarpine</a></li>
<li><span class="new">RS86</span></li>
<li>Sabcomeline</li>
<li><span class="new">SDZ 210-086</span></li>
<li><span class="new">Sebacylcholine</span></li>
<li><span class="new">Suberyldicholine</span></li>
<li>Talsaclidine</li>
<li>Tazomeline</li>
<li><span class="new">Thiopilocarpine</span></li>
<li>Vedaclidine</li>
<li><span class="new">VU-0029767</span></li>
<li><span class="new">VU-0090157</span></li>
<li><span class="new">VU-0152099</span></li>
<li><span class="new">VU-0152100</span></li>
<li>VU-0238429</li>
<li><span class="new">WAY-132,983</span></li>
<li>Xanomeline</li>
<li><span class="new">YM-796</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Quinuclidinyl benzilate</li>
<li>4-DAMP</li>
<li>Aclidinium bromide (+formoterol)</li>
<li>Abediterol</li>
<li><span class="new">AF-DX 250</span></li>
<li>AF-DX 384</li>
<li>Ambutonium bromide</li>
<li>Anisodamine</li>
<li>Anisodine</li>
<li>Antihistamines (first-generation) (e.g., <a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">brompheniramine</a>, <a href="Buclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buclizine" title="Buclizine">buclizine</a>, captodiame, <a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">chlorphenamine (chlorpheniramine)</a>, <a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">cinnarizine</a>, <a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">clemastine</a>, <a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">cyproheptadine</a>, <a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">dimenhydrinate</a>, dimetindene, <a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">diphenhydramine</a>, <a href="Doxylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxylamine" title="Doxylamine">doxylamine</a>, meclizine, <a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">mepyramine (pyrilamine)</a>, <a href="Mequitazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mequitazine" title="Mequitazine">mequitazine</a>, perlapine, <a href="Phenindamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenindamine" title="Phenindamine">phenindamine</a>, <a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">pheniramine</a>, phenyltoloxamine, <a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">promethazine</a>, <a href="Propiomazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Propiomazine" title="Propiomazine">propiomazine</a>, <a href="Triprolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triprolidine" title="Triprolidine">triprolidine</a>)</li>
<li><span class="new">AQ-RA 741</span></li>
<li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a></li>
<li>Atropine methonitrate</li>
<li>Atypical antipsychotics (e.g., <a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">clozapine</a>, fluperlapine, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a> (+fluoxetine), <span class="new">rilapine</span>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <span class="new">tenilapine</span>, zotepine)</li>
<li><a href="Benactyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benactyzine" title="Benactyzine">Benactyzine</a></li>
<li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine (benztropine)</a></li>
<li>Benzilone</li>
<li>Benzilylcholine mustard</li>
<li>Benzydamine</li>
<li><span class="new">BIBN 99</span></li>
<li><a href="Biperiden.htm" tppabs="https://ptable.com/wiki/compounds/A/Biperiden" title="Biperiden">Biperiden</a></li>
<li>Bornaprine</li>
<li>Camylofin</li>
<li>CAR-226,086</li>
<li>CAR-301,060</li>
<li>CAR-302,196</li>
<li><span class="new">CAR-302,282</span></li>
<li><span class="new">CAR-302,368</span></li>
<li><span class="new">CAR-302,537</span></li>
<li><span class="new">CAR-302,668</span></li>
<li>Caramiphen</li>
<li><a href="Cimetropium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetropium_bromide" title="Cimetropium bromide">Cimetropium bromide</a></li>
<li><a href="Clidinium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Clidinium_bromide" title="Clidinium bromide">Clidinium bromide</a></li>
<li>Cloperastine</li>
<li><span class="new">CS-27349</span></li>
<li><a href="Cyclobenzaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclobenzaprine" title="Cyclobenzaprine">Cyclobenzaprine</a></li>
<li><a href="Cyclopentolate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclopentolate" title="Cyclopentolate">Cyclopentolate</a></li>
<li><a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">Darifenacin</a></li>
<li><span class="new">DAU-5884</span></li>
<li>Desfesoterodine</li>
<li>Dexetimide</li>
<li><span class="new">DIBD</span></li>
<li><a href="Dicycloverine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicycloverine" title="Dicycloverine">Dicycloverine (dicyclomine)</a></li>
<li>Dihexyverine</li>
<li>Difemerine</li>
<li><a href="Diphemanil_metilsulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphemanil_metilsulfate" title="Diphemanil metilsulfate">Diphemanil metilsulfate</a></li>
<li>Ditran</li>
<li>EA-3167</li>
<li>EA-3443</li>
<li>EA-3580</li>
<li>EA-3834</li>
<li>Emepronium bromide</li>
<li>Etanautine</li>
<li>Etybenzatropine (ethybenztropine)</li>
<li><a href="Fenpiverinium.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenpiverinium" title="Fenpiverinium">Fenpiverinium</a></li>
<li>Fentonium bromide</li>
<li>Fesoterodine</li>
<li><a href="Flavoxate.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavoxate" title="Flavoxate">Flavoxate</a></li>
<li>Glycopyrronium bromide (+beclometasone/formoterol, +indacaterol)</li>
<li><span class="new">Hexahydrodifenidol</span></li>
<li><span class="new">Hexahydrosiladifenidol</span></li>
<li><span class="new">Hexbutinol</span></li>
<li>Hexocyclium</li>
<li>Himbacine</li>
<li><span class="new">HL-031,120</span></li>
<li>Homatropine</li>
<li>Imidafenacin</li>
<li><a href="Ipratropium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ipratropium_bromide" title="Ipratropium bromide">Ipratropium bromide</a> (+salbutamol)</li>
<li><a href="Isopropamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Isopropamide" title="Isopropamide">Isopropamide</a></li>
<li><span class="new">J-104,129</span></li>
<li><a href="Hyoscyamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyoscyamine" title="Hyoscyamine">Hyoscyamine</a></li>
<li>Mamba toxin 3</li>
<li>Mamba toxin 7</li>
<li>Mazaticol</li>
<li>Mebeverine</li>
<li>Meladrazine</li>
<li><a href="Mepenzolate.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepenzolate" title="Mepenzolate">Mepenzolate</a></li>
<li><a href="Methantheline.htm" tppabs="https://ptable.com/wiki/compounds/A/Methantheline" title="Methantheline">Methantheline</a></li>
<li>Methoctramine</li>
<li>Methylatropine</li>
<li><a href="Methylhomatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylhomatropine" title="Methylhomatropine" class="mw-redirect">Methylhomatropine</a></li>
<li><a href="Methylscopolamine_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylscopolamine_bromide" title="Methylscopolamine bromide">Methylscopolamine</a></li>
<li><a href="Metixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Metixene" title="Metixene">Metixene</a></li>
<li>Muscarinic toxin 7</li>
<li>N-Ethyl-3-piperidyl benzilate</li>
<li>N-Methyl-3-piperidyl benzilate</li>
<li>Nefopam</li>
<li><a href="Octatropine_methylbromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octatropine_methylbromide" title="Octatropine methylbromide">Octatropine methylbromide (anisotropine methylbromide)</a></li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><span class="new">Otenzepad (AF-DX 116)</span></li>
<li>Otilonium bromide</li>
<li>Oxapium iodide</li>
<li>Oxitropium bromide</li>
<li><a href="Oxybutynin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxybutynin" title="Oxybutynin">Oxybutynin</a></li>
<li><a href="Oxyphencyclimine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxyphencyclimine" title="Oxyphencyclimine">Oxyphencyclimine</a></li>
<li><a href="Oxyphenonium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxyphenonium_bromide" title="Oxyphenonium bromide">Oxyphenonium bromide</a></li>
<li><span class="new">PBID</span></li>
<li>PD-102,807</li>
<li>PD-0298029</li>
<li>Penthienate</li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine</a></li>
<li><span class="new">pFHHSiD</span></li>
<li>Phenglutarimide</li>
<li>Phenyltoloxamine</li>
<li>Pipenzolate bromide</li>
<li>Piperidolate</li>
<li><a href="Pirenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirenzepine" title="Pirenzepine">Pirenzepine</a></li>
<li>Piroheptine</li>
<li>Pizotifen</li>
<li>Poldine</li>
<li><a href="Pridinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pridinol" title="Pridinol">Pridinol</a></li>
<li>Prifinium bromide</li>
<li><a href="Procyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procyclidine" title="Procyclidine">Procyclidine</a></li>
<li><a href="Profenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Profenamine" title="Profenamine">Profenamine (ethopropazine)</a></li>
<li><a href="Propantheline_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Propantheline_bromide" title="Propantheline bromide">Propantheline bromide</a></li>
<li>Propiverine</li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li>Revefenacin</li>
<li>Rociverine</li>
<li><span class="new">RU-47,213</span></li>
<li><span class="new">SCH-57,790</span></li>
<li><span class="new">SCH-72,788</span></li>
<li><span class="new">SCH-217,443</span></li>
<li>Scopolamine (hyoscine)</li>
<li>Scopolamine butylbromide (hyoscine butylbromide)</li>
<li><span class="new">Silahexacyclium</span></li>
<li><span class="new">Sofpironium bromide</span></li>
<li><a href="Solifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Solifenacin" title="Solifenacin">Solifenacin</a></li>
<li><abbr>SSRIs</abbr> (e.g., femoxetine, <a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">paroxetine</a>)</li>
<li><a href="Telenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Telenzepine" title="Telenzepine">Telenzepine</a></li>
<li>Terodiline</li>
<li>Tetracyclic antidepressants (e.g., <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">amoxapine</a>, <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a>, <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li>Tiemonium iodide</li>
<li>Timepidium bromide</li>
<li><a href="Tiotropium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiotropium_bromide" title="Tiotropium bromide">Tiotropium bromide</a></li>
<li><span class="new">Tiquizium bromide</span></li>
<li>Tofenacin</li>
<li><a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a> (+perphenazine), amitriptylinoxide, butriptyline, cidoxepin, <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, desipramine, <span class="new">desmethyldesipramine</span>, dibenzepin, dosulepin (dothiepin), <a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">doxepin</a>, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, lofepramine, nitroxazepine, northiaden (desmethyldosulepin), <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>, <a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">protriptyline</a>, quinupramine, <a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">trimipramine</a>)</li>
<li><a href="Tridihexethyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Tridihexethyl" title="Tridihexethyl">Tridihexethyl</a></li>
<li><a href="Trihexyphenidyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Trihexyphenidyl" title="Trihexyphenidyl">Trihexyphenidyl</a></li>
<li>Trimebutine</li>
<li><span class="new">Tripitamine (tripitramine)</span></li>
<li><span class="new">Tropacine</span></li>
<li>Tropatepine</li>
<li><a href="Tropicamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropicamide" title="Tropicamide">Tropicamide</a></li>
<li><a href="Trospium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Trospium_chloride" title="Trospium chloride">Trospium chloride</a></li>
<li>Typical antipsychotics (e.g., <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Chlorprothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorprothixene" title="Chlorprothixene">chlorprothixene</a>, cyamemazine (cyamepromazine), <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Mesoridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesoridazine" title="Mesoridazine">mesoridazine</a>, <a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">thioridazine</a>)</li>
<li>Umeclidinium bromide (+vilanterol)</li>
<li>WIN-2299</li>
<li>Xanomeline</li>
<li><span class="new">Zamifenacin</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Precursors<br><small>(and prodrugs)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acetyl-coA</li>
<li>Adafenoxate</li>
<li><a href="Choline.htm" tppabs="https://ptable.com/wiki/compounds/A/Choline" title="Choline">Choline</a> (<a href="Lecithin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lecithin" title="Lecithin">lecithin</a>)</li>
<li><a href="Citicoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Citicoline" title="Citicoline">Citicoline</a></li>
<li>Cyprodenate</li>
<li><a href="Dimethylethanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethylethanolamine" title="Dimethylethanolamine">Dimethylethanolamine</a></li>
<li>Glycerophosphocholine</li>
<li>Meclofenoxate (centrophenoxine)</li>
<li><a href="Phosphatidylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphatidylcholine" title="Phosphatidylcholine">Phosphatidylcholine</a></li>
<li><a href="Phosphatidylethanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphatidylethanolamine" title="Phosphatidylethanolamine">Phosphatidylethanolamine</a></li>
<li>Phosphorylcholine</li>
<li>Pirisudanol</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Nicotinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators</i></div></td></tr></tbody></table></div><span>
</span>








<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-06" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Solifenacin&oldid=971416116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Solifenacin&oldid=971416116'" tppabs="https://en.wikipedia.org/wiki/?title=Solifenacin&oldid=971416116">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>